DCGI Recommends Covovax As Heterologous Booster Dose

New Delhi : The Central drug regulatory authority Drugs Controller General of India (DCGI) has recommended market authorisation for Serum Institute of India’s Covid vaccine Covovax as a heterologous booster dose for those who have already taken two doses of Covishield or Covaxin.

Earlier, DCGI had approved Covovax for restricted use in emergency situations in adults on December 28, 2021, for age between 12-17 on March 9, 2022, and for children under 7- 11 years on 28th June 2022 subject to certain conditions.

Covovax is manufactured through technology transfer from Novavax. The European Medicines Agency has approved it for conditional marketing authorization.

It was granted an emergency-use listing by the World Health Organization (WHO) on December 17, 2021.

Recently, Bharat Biotech’s nasal Covid vaccine for adults above 18-year-old had been approved by the Government of India and will be used as a heterologous booster dose.

The vaccine will be available in private hospitals.

Related Posts

  • Pharma
  • June 19, 2024
  • 70 views
Dermatologists Raise Concern Over Rising Skin Conditions In India

Mumbai: Dermatologists have noticed a significant increase in various skin conditions in India in recent years. Issues range from fungal infections, acne and hair loss to pigmentation. Dr. Sonali Kohli, a…

  • Pharma
  • June 19, 2024
  • 114 views
Expert Panel To Soon Weigh Plan To Use Generics For Prescription Drugs

New Delhi: An expert committee is likely to meet soon to deliberate on a contentious proposal to assess the feasibility of allowing generic substitutions for prescription drugs, said people familiar with…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Dermatologists Raise Concern Over Rising Skin Conditions In India

Dermatologists Raise Concern Over Rising Skin Conditions In India

Expert Panel To Soon Weigh Plan To Use Generics For Prescription Drugs

Expert Panel To Soon Weigh Plan To Use Generics For Prescription Drugs

Telangana Anti-Narcotics Bureau Seals Alprazolam Manufacturing Unit

Telangana Anti-Narcotics Bureau Seals Alprazolam Manufacturing Unit

Structurally & Phonetically Similar Trademark Can’t Be Registered: Bombay HC

Structurally & Phonetically Similar Trademark Can’t Be Registered: Bombay HC

FDI Inflow Into Hospitals & Diagnostic Centres Grows 89 Per Cent In 2023-24

FDI Inflow Into Hospitals & Diagnostic Centres Grows 89 Per Cent In 2023-24

Ayush Ministry, Raj Govt Yet To Act Against Firm Selling Homoeopathic ‘Insulin’

Ayush Ministry, Raj Govt Yet To Act Against Firm Selling Homoeopathic ‘Insulin’